In this Editorial Article, Heather Watson, Senior Manager in the Immunochemistry Department at Labcorp highlights how the industry is improving patient care by delivering innovative solutions that support faster and more cost-effective treatment.
The article also deals with the regulatory challenges in biosimilar development and how to address those challenges through in-house efforts or by partnering with other organizations offering specialized services and products in this area, such as Labcorp and Svar Life Science.